Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Bonnefoi, Hervé; MacGrogan, Gaetan; Poncet, Coralie; Iggo, Richard; Pommeret, Fanny; Grellety, Thomas; Larsimont, Denis; Bécette, Véronique; Kerdraon, Olivier; Bibeau, Frédéric; Ghnassia, Jean-Pierre; Picquenot, Jean-Michel; Thomas, Jeremy; Tille, Jean-Christophe; Slaets, Leen; Bodmer, Alexandre; Bergh, Jonas; Cameron, David

doi:10.1038/s41416-019-0420-y

Scientific article

English

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

ContributorsBonnefoi, Hervé; MacGrogan, Gaetan; Poncet, Coralie; Iggo, Richard; Pommeret, Fanny; Grellety, Thomas; Larsimont, Denis; Bécette, Véronique; Kerdraon, Olivier; Bibeau, Frédéric; Ghnassia, Jean-Pierre; Picquenot, Jean-Michel; Thomas, Jeremy; Tille, Jean-Christophe; Slaets, Leen; Bodmer, Alexandre; Bergh, Jonas; Cameron, David

Published inBritish Journal of Cancer, vol. 120, no. 9, p. 913-921

Publication date2019

Abstract

We explored, within the EORTC10994 study, the outcomes for patients with molecular apocrine (MA) breast cancer, and defined immunohistochemistry (IHC) as androgen-receptor (AR) positive, oestrogen (ER) and progesterone (PR) negative. We also assessed the concordance between IHC and gene expression arrays (GEA) in the identification of MA cancers.

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Citation (ISO format)

BONNEFOI, Hervé et al. Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. In: British Journal of Cancer, 2019, vol. 120, n° 9, p. 913–921. doi: 10.1038/s41416-019-0420-y

Article (Published version)

CC BY

Identifiers

PID : unige:116914
DOI : 10.1038/s41416-019-0420-y
PMID : 30899086

ISSN of the journal0007-0920

318views

157downloads

Creation04/04/2019 13:57:00

First validation04/04/2019 13:57:00

Update time15/03/2023 16:26:45

Status update15/03/2023 16:26:43

Last indexation02/10/2024 19:46:24

Archive ouverte UNIGE

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Technical informations